Literature DB >> 28388228

Clinical management of severe therapy-resistant asthma.

Kian Fan Chung1,2.   

Abstract

INTRODUCTION: Severe therapy-resistant asthma is an area where there has been recent advances in understanding that is percolating into improvements in management. Areas covered: This review covers the recent definition and approach to the diagnosis of severe asthma and its differentiation from difficult-to-treat asthma. The recent advances in phenotyping severe asthma and in ensuing changes in management approaches together with the introduction of new therapies are covered from a review of the recent literature. Expert commentary: After ascertaining the diagnosis of severe asthma, patients need to be treated adequately with existing therapies. The management approach to severe asthma now comprises of a phenotyping step for the definition of either an allergic or eosinophilic severe asthma for which targeted therapies are currently available. This will lead to a precision medicine approach to the management of severe asthma.

Entities:  

Keywords:  Severe asthma; asthma guidelines; difficult-to-treat asthma; eosinophilic asthma; exhaled nitric oxide; management of asthma; phenotyping

Mesh:

Year:  2017        PMID: 28388228     DOI: 10.1080/17476348.2017.1317597

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  5 in total

1.  The Importance of Flexible Bronchoscopy in Difficult-to-treat Asthma from a Pediatric Pulmonology Perspective.

Authors:  Halime Nayir Büyükşahin; Nagehan Emiralioğlu; Dilber Ademhan Tural; Beste Özsezen; Birce Sunman; İsmail Güzelkaş; Ebru Yalçın; Deniz Doğru; Uğur Özçelik; Nural Kiper
Journal:  Turk Arch Pediatr       Date:  2022-05

2.  Effect of the BMPR-II-SMAD3/MRTF pathway on proliferation and migration of ASMCs and the mechanism in asthma.

Authors:  Wenbo Gu; Jiahui Lei; He Zhu; Yali Xiao; Zhenping Zhang; Limin Zhao
Journal:  Mol Biol Rep       Date:  2022-08-25       Impact factor: 2.742

3.  Transcutaneous systemic photobiomodulation reduced lung inflammation in experimental model of asthma by altering the mast cell degranulation and interleukin 10 level.

Authors:  Paula Tatiane Alonso; Adriana Schapochnik; Simone Klein; Robson Brochetti; Amílcar Sabino Damazo; Maria Fernanda de Souza Setubal Destro; Adriana Lino-Dos-Santos-Franco
Journal:  Lasers Med Sci       Date:  2021-06-19       Impact factor: 3.161

4.  The efficacy of Tuina for asthma: A protocol for a systematic review and meta-analysis.

Authors:  Changhong Wang; Yong Jiang; Zhipeng Fan; Mao Zhao; Yuchang Jiang; Zhaodi Wang; Zhaoxing Chen
Journal:  Medicine (Baltimore)       Date:  2020-12-24       Impact factor: 1.817

Review 5.  Long-term, low-dose macrolide antibiotic treatment in pediatric chronic airway diseases.

Authors:  Jialiang Sun; Yanan Li
Journal:  Pediatr Res       Date:  2021-06-12       Impact factor: 3.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.